Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14720
Articles
Company
Deals
Zhejiang Gongdong to Acquire Trademark Plastics for Overseas Expansion
January 20, 2025
Company
Innovent Biologics Posts Strong Q4 Revenues Amid COVID-19 Challenges
January 20, 2025
Company
Deals
Shanghai Weimu Medical Raises Pre-Series A+ Funding for Clinical Development
January 20, 2025
Company
Deals
MicroPort Endovascular Plans RMB 2.55 Billion Private Placement
January 20, 2025
Company
Drug
OcuMension’s Phase I Study for Dry Eye Treatment OT-202 Concludes
January 20, 2025
Company
Eli Lilly Reports Q4 Financials with COVID-19 Impact and Market Performers
January 20, 2025
Company
Deals
Virpax Pharmaceuticals Seeks China Licensing Partner for Non-Opioid Pain Drug Envelta
January 20, 2025
Company
Novo Nordisk Posts Strong 2022 Results; GLP-1 Therapies Drive Growth
January 20, 2025
Company
Drug
Antengene Launches Phase I CLINCH Study for ATG-022 in Australia
January 20, 2025
Company
Drug
Henlius Begins Phase I Trial for Biosimilar HLX15 Targeting Multiple Myeloma
January 20, 2025
Company
Deals
NeuShen Therapeutics Partners with UMass Chan for ALS Gene Therapy Development
January 20, 2025
Company
Deals
F-Star Therapeutics and Sino Biopharmaceutical Seek CFIUS Approval with Extended Deadline
January 20, 2025
1
2
…
1,062
1,063
1,064
1,065
1,066
…
1,226
1,227
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?